Back to the main directory
EarningsReview / Equity
- IQE - Termination of coverage by Edison Investment Research
- Avon Protection - Termination of coverage by Edison Investment Research
- CI Games - Q122 shows continuing progress by Edison Investment Research
- Helios Underwriting - Lloyd’s upswing set to continue strongly by Edison Investment Research
- Kopy Goldfields - Termination of coverage by Edison Investment Research
- Pharnext - PREMIER trial completes patient recruitment by Edison Investment Research
- Indofood Sukses Makmur (INDF IJ) by HSBC
- Tiger Brands Ltd (TBS SJ) by HSBC
- Supply woes behind miss, but should ease from here by BNP Paribas Exane
- WOOD Flash – 4iG: 1Q22 results review – solid quarter, but broadly in line with our expectations by Wood and Company
- Investment Daily 01/06/2022 by BNP Paribas Exane
- 宏发股份（600885 CH） by HSBC
- EQUITA SIM: MERCK (BUY; unchanged): 1Q22 results by Equita Sim
- FQ1''23 postview: Salesforce addresses key investor concerns head on by BNP Paribas Exane
- Evolution (Buy, TP: SEK1800.00) - Lightning in a bottle by DnB Markets
- Norva24 (Buy, TP: SEK38.00) - Nordstjernan enters as new owner by DnB Markets
- 4iG - Consolidation, integration and synergies by Edison Investment Research
- SAS (SAS SS) by HSBC
- U.S. Auto SAAR: May Malaise at 12.81M by BNP Paribas Exane
- WOOD Daily: Polish banks, KOFOL CP, AUG1L LH, CIE PW, DAT PW, HUG PW, CAR PW, PZU PW, TEN PW, GPW PW, WPL/CPS PW, 4iG HU, A4L BU, The Rear-View Mirror by Wood and Company
- China’s poultry industry by HSBC
- Crossroads of the world by BNP Paribas Exane
- Wuliangye (000858 CH) by HSBC
- FY22 results and 15 questions for management by BNP Paribas Exane
- Guard Therapeutics - Global Phase 2 trial initiated by Danske Bank Equity Research